2000
DOI: 10.1128/jcm.38.2.763-767.2000
|View full text |Cite
|
Sign up to set email alerts
|

Resistance of Trichomonas vaginalis to Metronidazole: Report of the First Three Cases from Finland and Optimization of In Vitro Susceptibility Testing under Various Oxygen Concentrations

Abstract: Trichomonas vaginalis is a globally common sexually transmitted human parasite. Many strains of T. vaginalis from around the world have been described to be resistant to the current drug of choice, metronidazole. However, only a few cases of metronidazole resistance have been reported from Europe. The resistant strains cause prolonged infections which are difficult to treat. T. vaginalis infection also increases the risk for human immunodeficiency virus transmission. We present a practical method for determini… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
14
0
2

Year Published

2009
2009
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 66 publications
(18 citation statements)
references
References 38 publications
2
14
0
2
Order By: Relevance
“…In the present study, none of the clinical isolates exhibited resistance to MTZ under aerobic or anaerobic conditions with MIC <25.0 µg/ml and <6.3 µg/ml, respectively. These results conform with most reports from Egypt and other countries, where majority of clinical isolates were susceptible to MTZ with few resistant strains from USA, Europe and Africa [25,43,47,48] . It is worth mentioning that, in the present study, isolate 3 which exhibited the highest MIC of 25.0 µg/ml and 6.3 µg/ml under aerobic and anaerobic conditions, respectively, had the lowest significant growth peak of 40.5±21 after 96 h. Another study proposed different threshold concentrations of the 5-nitroimidazole drugs [47] .…”
Section: Discussionsupporting
confidence: 91%
See 2 more Smart Citations
“…In the present study, none of the clinical isolates exhibited resistance to MTZ under aerobic or anaerobic conditions with MIC <25.0 µg/ml and <6.3 µg/ml, respectively. These results conform with most reports from Egypt and other countries, where majority of clinical isolates were susceptible to MTZ with few resistant strains from USA, Europe and Africa [25,43,47,48] . It is worth mentioning that, in the present study, isolate 3 which exhibited the highest MIC of 25.0 µg/ml and 6.3 µg/ml under aerobic and anaerobic conditions, respectively, had the lowest significant growth peak of 40.5±21 after 96 h. Another study proposed different threshold concentrations of the 5-nitroimidazole drugs [47] .…”
Section: Discussionsupporting
confidence: 91%
“…These results conform with most reports from Egypt and other countries, where majority of clinical isolates were susceptible to MTZ with few resistant strains from USA, Europe and Africa [25,43,47,48] . It is worth mentioning that, in the present study, isolate 3 which exhibited the highest MIC of 25.0 µg/ml and 6.3 µg/ml under aerobic and anaerobic conditions, respectively, had the lowest significant growth peak of 40.5±21 after 96 h. Another study proposed different threshold concentrations of the 5-nitroimidazole drugs [47] . In this aspect isolate number 3 would be considered resistant under anaerobic conditions according to Matini et al [43] who proposed a threshold concentration of 3.2 µg/ml under anaerobic conditions.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Parasites were challenged with graded concentrations of S. aromaticum essential oil (300, 200, 100, 50, 25 μg/ml), and MTZ (500 µg/ml and 1 mg/ml). The tested cultures were examined at 24, 48, 72 and 96 h. The minimal lethal concentrations (MLCs) was considered as the lowest drug concentration needed to reach the maximum reduction of growth and multiplication of the parasite in vitro up to no growth [25] . MLCs of S. aromaticum essential oil (300, 200, 100, 50, 25 μg/ ml) and MTZ were determined by parasite counting.…”
Section: Determination Of Mlcsmentioning
confidence: 99%
“…T. vaginalis is an established cause of sexually transmitted diseases (STDs) and currently affects at least170 million people worldwide; more than gonorrhea, syphilis and Chlamydia combined [2]- [4]. The organism has been reported to cause pneumonia, bronchitis and oral lesions [5], [6], while a greenish-yellow frothy vaginal secretion and itching are its commonest presentations [7]- [9]. Infertility, premature rupture of membranes, preterm labor, and abortions has all been associated with the organism [10].…”
Section: Introductionmentioning
confidence: 99%